CAS 2300982-44-7

RIPK1-IN-7

CAS: 2300982-44-7

RIPK1-IN-7: Strong, selective RIPK1 inhibitor (Kd=4 nM, IC50=11 nM) with great antimetastasis effects in B16 melanoma.

Fórmula: C₂₅H₂₂F₃N₅O₂

Pureza: 98.02% - 98.18%

Forma y color: Solid

Peso molecular: 481.47

Ref: TM-T12731

RIPK1-IN-7

CAS: 2300982-44-7

Fórmula: C₂₅H₂₂F₃N₅O₂

Pureza: %

Forma y color: Solid

Peso molecular: 481.4697

Ref: IN-DA01V4EB

1-[5-(4-Amino-7-Ethyl-7H-Pyrrolo[2,3-d]Pyrimidin-5-yl)-2,3-Dihydro-1H-Indol-1-yl]-2-[3-(Trifluoromethoxy)phenyl]-Ethanone

CAS: 2300982-44-7

1-[5-(4-Amino-7-Ethyl-7H-Pyrrolo[2,3-d]Pyrimidin-5-yl)-2,3-Dihydro-1H-Indol-1-yl]-2-[3-(Trifluoromethoxy)phenyl]-Ethanone

Pureza: 97%

Peso molecular: 481.47g/mol

Ref: 54-PC108635

RIPK1-IN-7

CAS: 2300982-44-7

RIPK1-IN-7

Pureza: ≥95%

Peso molecular: 481.47g/mol

Ref: 54-BUP04529

RIPK1-IN-7

CAS: 2300982-44-7

RIPK1-IN-7 is an apoptosis inducer that acts as a histone deacetylase inhibitor. It induces cell death by binding to the mitochondrial membrane, which leads to the release of cytochrome c and other pro-apoptotic factors. RIPK1-IN-7 has been shown to be effective in low doses in vitro, but not in vivo, with necroptosis being a possible mechanism for its lack of activity.

Fórmula: C₂₅H₂₂F₃N₅O₂

Pureza: Min. 95%

Peso molecular: 481.5 g/mol

Ref: 3D-ASD98244